ICON Plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company specializes in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON has the operational flexibility to provide development services on a stand-alone basis or as part of a full-service solution.

With headquarters in Dublin, Ireland, ICON currently has over 9,400 employees, operating from 82 locations in 40 countries.

Contract research organization (CRO) ICON is not iconic yet, but it would like to be. By the time a new drug hits the market, it has passed through a series of clinical trials to demonstrate its safety and effectiveness; guiding drugs through that process is what ICON does best. The company provides drugmakers and medical device companies around the world with a broad range of services for their product candidates' clinical trials. ICON designs studies and recruits investigators; manages and analyzes trial data; writes reports and other documents; and assists with regulatory filings. Spanning the full development cycle, it also helps with preclinical drug development and post-approval safety monitoring.

HQ Address: 

South County Business Park
Leopardstown; Dublin 18

HQ Country: 
HQ State: 
HQ City: 
(+353) 1-291-2000